Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 18704972.
- Also identified by DOI 10.1002/hed.20876.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The epidermal growth factor receptor (EGFR) and the inhibitor of apoptosis protein survivin play important roles in the regulation of cellular proliferation and survival in squamous cell carcinomas. Their correlation in oropharyngeal squamous cell carcinoma (OSCC) has not been evaluated yet. In this multicenter study, we analyzed the expression of survivin and EGFR in tissue specimens from 73 selected patients with OSCC using immunohistochemistry. Higher cytoplasmic survivin scores were significantly correlated with high scores of EGFR expression (p=.013). Nuclear survivin expression was associated with a poor overall survival rate with an estimated 3-year overall survival probability of 17.3% versus 87.4% for non-nuclear expression of survivin (p<.001). Multivariate analysis revealed that nuclear survivin expression was an independent negative prognostic factor (p=.008). Considering the strong impact of nuclear survivin expression on survival, the survivin expression should be prospectively evaluated to select patients with an increased risk for disease recurrence.
Medical subject headings
- Biomarkers, Tumor
- Carcinoma, Squamous Cell
- Cysteine Proteinase Inhibitors
- ErbB Receptors
- Microtubule-Associated Proteins
- Neoplasm Proteins
- Oropharyngeal Neoplasms